OLANZAPINE ODT TEVA ® 5 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

OLANZAPINE 5 MG

Mevcut itibaren:

SALOMON,LEVIN & ELSTEIN LTD

ATC kodu:

N05AH03

Farmasötik formu:

TABLETS ORODISPERSIBLE

Uygulama yolu:

PER OS

Tarafından üretildi:

TEVA OPERATIONS POLAND SP.ZO.O

Terapötik grubu:

OLANZAPINE

Terapötik endikasyonlar:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Yetkilendirme tarihi:

2011-05-01